Mirodenafil: a new PDE5 inhibitor for the treatment of erectile dysfunction

被引：0
|
作者：
机构：
来源：
Nature Clinical Practice Urology | 2009年 / 6卷 / 2期
关键词：
D O I：
10.1038/ncpuro1281
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：60 / 60
相关论文
共 50 条
  • [41] Physical Activity and PDE5 Inhibitors in the Treatment of Erectile Dysfunction: Results of a Randomized Controlled Study
    Maio, Giuseppe
    Saraeb, Salim
    Marchiori, Antonio
    JOURNAL OF SEXUAL MEDICINE, 2010, 7 (06): : 2201 - 2208
  • [42] PHARMACOKINETICS OF AVANAFIL; A NOVEL, RAPIDLY-ABSORBED, SELECTIVE PDE5 INHIBITOR FOR THE TREATMENT OF MILD TO SEVERE ERECTILE DYSFUNCTION (ED)
    Allison, M.
    Grant, T.
    Obaidi, M.
    Marenco, T.
    Yee, S.
    Day, W.
    JOURNAL OF SEXUAL MEDICINE, 2011, 8 : 466 - 467
  • [43] Treatment for erectile dysfunction based on patient-reported outcomes -: To every man the PDE5 inhibitor that he finds superior
    Hedelin, H
    Ströberg, P
    DRUGS, 2005, 65 (16) : 2245 - 2251
  • [44] Quinolines as extremely potent and selective PDE5 inhibitors as potential agents for treatment of erectile dysfunction
    Bi, YZ
    Stoy, P
    Adam, L
    He, B
    Krupinski, J
    Normandin, D
    Pongrac, R
    Seliger, L
    Watson, A
    Macor, JE
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (06) : 1577 - 1580
  • [45] A 6 month, prospective, observational study of PDE5 inhibitor treatment persistence and adherence in Latin American men with erectile dysfunction
    Rubio-Aurioles, Eusebio
    Antonio Reyes, Luis
    Borregales, Leonardo
    Cairoli, Carlos
    Sorsaburu, Sebastian
    CURRENT MEDICAL RESEARCH AND OPINION, 2013, 29 (06) : 695 - 706
  • [46] Substituted pyrazolopyridines as potent and selective PDE5 inhibitors: Potential agents for treatment of erectile dysfunction
    Yu, GX
    Mason, HJ
    Wu, XM
    Wang, J
    Chong, SH
    Dorough, G
    Henwood, A
    Pongrac, R
    Seliger, L
    He, B
    Normandin, D
    Adam, L
    Krupinski, J
    Macor, JE
    JOURNAL OF MEDICINAL CHEMISTRY, 2001, 44 (07) : 1025 - 1027
  • [47] Is Penile Length a Factor in Treatment of Erectile Dysfunction With PDE-5 Inhibitor?
    Savas, Murat
    Yeni, Ercan
    Ciftci, Halil
    Topal, Ufuk
    Utangac, Mazhar
    Verit, Ayhan
    JOURNAL OF ANDROLOGY, 2009, 30 (05): : 515 - 519
  • [48] WHAT IS THE OVERALL SAFETY AND EFFICACY OF INHIBITORS OF THE PHOSPHODIESTERASE TYPE 5 ENZYME (PDE5) IN THE TREATMENT OF ERECTILE DYSFUNCTION?
    Ezquer, A. J.
    Gilli, F. A.
    Cenice, F. F.
    JOURNAL OF SEXUAL MEDICINE, 2012, 9 : 89 - 89
  • [49] EFFICACY OF AS NEEDED PDE5 INHIBITOR THERAPY VS. TADALAFIL ONCE DAILY ON IMPROVEMENT IN ERECTILE DYSFUNCTION
    Kim, Edward
    Seftel, Allen
    Goldfischer, Evan
    Baygani, Simin
    Burns, Patrick
    JOURNAL OF SEXUAL MEDICINE, 2014, 11 : 176 - 177
  • [50] THE RESULT OF THE PERSONALITY ASSESSMENT BY EGOGRAM MAY PREDICT THE EFFECTIVENESS OF THE PDE5 INHIBITOR FOR THE PATIENTS WITH PSYCHOGENIC ERECTILE DYSFUNCTION
    Imai, Shin
    Yoshida, Masashi
    Yoneda, Tatsuaki
    Kudoh, Shinya
    JOURNAL OF SEXUAL MEDICINE, 2013, 10 : 216 - 217
12345